Portola Valley, CA, United States of America

Dennis Lanfear

This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Intekrin Therapeutics, Inc.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis Lanfear. Retrieved from https://idiyas.com/inventor/dennis-lanfear

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dennis Lanfear: Innovator in Pharmaceutical Compositions

Introduction

Dennis Lanfear is a notable inventor based in Portola Valley, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid pharmaceutical compositions.

Latest Patents

Lanfear holds 1 patent for his invention titled "Solid pharmaceutical compositions of PPARγ modulator." This patent provides pharmaceutical compositions in solid form that comprise a selective modulator of PPAR-γ, suitable for oral dosage to treat subjects with PPAR-γ mediated conditions. The patent also outlines methods for manufacturing these compositions and methods for treating PPAR-γ mediated conditions.

Career Highlights

Dennis Lanfear is associated with Intekrin Therapeutics, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in the field has positioned him as a valuable asset to the company.

Collaborations

Some of his notable coworkers include Kathleen M Lee and Linda Shawn Higgins, who contribute to the collaborative environment at Intekrin Therapeutics, Inc.

Conclusion

Dennis Lanfear's work in pharmaceutical compositions showcases his innovative spirit and dedication to improving healthcare solutions. His contributions are significant in the ongoing development of treatments for PPAR-γ mediated conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…